Disease staging and sub setting of interstitial lung disease associated with systemic sclerosis: impact on therapy.

Abstract excerpt

INTRODUCTION: Interstitial lung disease (ILD) is the most serious complication of systemic sclerosis (SSc). There is no accepted guidance as to which clinical, radiological or physiological thresholds should prompt initiation or changes in treatment. Furthermore, some patients with extensive disease remain stable without the need for intervention whilst others with limited disease at the outset, experience a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Evidence-Based Medicine
• Share to Immunosuppressive Agents